ArticleFrontiers in immunology2025

Editorial: New avenues for the development of advanced immunotherapies: capitalizing on studies of the B and T cell receptor repertoire.

Fabio Nicolini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.